Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn’s disease and ulcerative colitis – experiences from a single center - Concepedia

Concepedia

Publication | Closed Access

Efficacy of the new infliximab biosimilar CT-P13 induction therapy in Crohn’s disease and ulcerative colitis – experiences from a single center

92

Citations

15

References

2015

Year

Klaudia Farkas, Mariann Rutka, Anita Bálint, Ferenc Nagy, Renáta Bor, Ágnes Milassin, Zoltán Szepes, Tamás Molnár

Expert Opinion on Biological Therapy

Abstract

This was the first study to prospectively evaluate the outcome of CT-P13 induction therapy in CD and UC. Our results confirm that induction with CT-P13 is safe and effective.

References

	Year	Citations

Page 1